Search Results - "Soukup, O"
-
1
Antimicrobial susceptibility testing: currently used methods and devices and the near future in clinical practice
Published in Journal of applied microbiology (01-10-2020)“…Summary Rapid identification of pathogen and its resistance to antimicrobial drugs, and subsequent appropriate antimicrobial treatment are essential for…”
Get full text
Journal Article -
2
The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease
Published in European journal of medicinal chemistry (25-04-2018)“…Novel tacrine-benzyl quinolone carboxylic acid (tacrine-BQCA) hybrids were designed based on multi-target directed ligands (MTLDs) paradigm, synthesized and…”
Get full text
Journal Article -
3
UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes
Published in Journal of pharmaceutical and biomedical analysis (05-02-2023)“…Tacrine was the first drug used in the therapy of Alzheimer’s disease (AD) and is one of the leading structures frequently pursued in the drug discovery of…”
Get full text
Journal Article -
4
The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors
Published in Archives of toxicology (01-04-2013)“…Organophosphorus inhibitors (OP) of acetylcholinesterase (AChE) represent a group of highly toxic compounds. The treatment of OP intoxication is, however,…”
Get full text
Journal Article -
5
Tetroxime: reactivation potency - in vitro and in silico study
Published in RSC advances (01-01-2017)“…Acetylcholinesterase (AChE) reactivators (oximes) are generally used as treatment in cases of nerve agent poisoning. There is no single oxime applicable in…”
Get full text
Journal Article -
6
Assessment of DNA-binding affinity of cholinesterase reactivators and electrophoretic determination of their effect on topoisomerase I and II activity
Published in Molecular bioSystems (16-08-2016)“…In this paper, we describe the biochemical properties and biological activity of a series of cholinesterase reactivators (symmetrical bisquaternary…”
Get more information
Journal Article -
7
The Effect of Chemical Structure of OEG Ligand Shells with Quaternary Ammonium Moiety on the Colloidal Stabilization, Cellular Uptake and Photothermal Stability of Gold Nanorods
Published in International journal of nanomedicine (01-01-2021)“…Plasmonic photothermal cancer therapy by gold nanorods (GNRs) emerges as a promising tool for cancer treatment. The goal of this study was to design cationic…”
Get full text
Journal Article -
8
Interaction of nerve agent antidotes with cholinergic systems
Published in Current medicinal chemistry (01-06-2010)“…The poisoning with organophosphorus compounds represents a life threatening danger especially in the time of terroristic menace. No universal antidote has been…”
Get more information
Journal Article -
9
A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication
Published in Toxicology research (Cambridge) (01-07-2016)“…Chemical warfare agents constitute an increasing threat to both military and civilian populations. Therefore, effective prophylactic approaches are urgently…”
Get full text
Journal Article -
10
The interaction of standard oxime reactivators with hemicholinium-3 sensitive choline carriers
Published in Toxicology letters (03-08-2012)“…► We investigated non-reactivating properties of standard oxime reactivators. ► We report their effect on hemicholinium-3 sensitive carriers. ► We show…”
Get full text
Journal Article -
11
The effect of oxime reactivators on muscarinic receptors: Functional and binding examinations
Published in Environmental toxicology and pharmacology (01-05-2011)“…Abstract The antidotal treatment of organophosphorus poisoning is still a problematic issue since no versatile antidote has been developed yet. In our study,…”
Get full text
Journal Article -
12
The interaction of quaternary reversible acetylcholinesterase inhibitors with the nicotinic receptor
Published in Physiological research (01-01-2014)“…Acetylcholinesterase inhibitors (AChEIs) are used in the treatment of myasthenia gravis (MG). We investigated the effects of AChEIs on peripheral nicotinic…”
Get full text
Journal Article -
13
Oxime reactivators and their in vivo and in vitro effects on nicotinic receptors
Published in Physiological research (01-01-2011)“…Current treatment of organophosphorus poisoning, resulting in overstimulation and desensitization of muscarinic and nicotinic receptors by acetylcholine (ACh),…”
Get full text
Journal Article -
14
Novel acetylcholinesterase reactivator K112 and its cholinergic properties
Published in Biomedicine & pharmacotherapy (01-10-2010)“…Abstract The oxime reactivator K112 is a member of the new group of xylene linker-containing AChE reactivators. Its cholinergic properties could be of…”
Get full text
Journal Article -
15
Pralidoxime--the gold standard of acetylcholinesterase reactivators--reactivation in vitro efficacy
Published in Bratislavské lékarské listy (2010)“…In this work, we aim to summarize the universality of this compound, its reactivation potential when different cholinesterase inhibitors are used. Pralidoxime…”
Get more information
Journal Article -
16
7-methoxyderivative of tacrine is a potent open channel blocker of NMDA receptors
Published in Journal of the neurological sciences (15-10-2017)Get full text
Journal Article -
17
Non-peptide orexin 2 receptor modulators as promising way to treatment of narcolepsy/insomnia
Published in Journal of the neurological sciences (15-10-2019)Get full text
Journal Article -
18
P.525 Tacrine derivatives as potent inhibitors of N-methyl-D-aspartate receptors with neuroprotective activity
Published in European neuropsychopharmacology (01-12-2019)Get full text
Journal Article -
19
Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation
Published in ACS chemical biology (15-09-2023)“…Tacrine was withdrawn from clinical use as a drug against Alzheimer’s disease in 2013, mainly due to drug-induced liver injury. The culprit of…”
Get full text
Journal Article -
20
Tacrine - tryptophan derivatives – novel agents against the Alzheimer’s disease
Published in Journal of the neurological sciences (15-10-2017)Get full text
Journal Article